Kenyon Lawrence A

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Kenyon Lawrence A
CIK #0001230484
EDGAR Form CIK 2011 - 2026
3 [0001230484]
4 [0001230484]
Form 3/4/5 Subject 2011 - 2026
Outlook Therapeutics Inc
Kenyon Lawrence A
Arno Therapeutics Inc
Tamir Biotechnology Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Outlook Therapeutics Inc OTLK
Common Stock
2024-09-26 Buy 5,000 $5.69 28,450
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
2024-03-20 Grant 12,500 $0.00
Outlook Therapeutics Inc OTLK
Common Stock
2021-04-20 Buy 10,000 $1.83 18,300
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
2020-10-01 Grant 3,668,984 $0.00
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
2020-07-17 Grant 450,000 $0.00
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
2020-03-19 Grant 216,435 $0.00
Outlook Therapeutics Inc OTLK
Common Stock
2019-09-18 Sell 1,350 $1.70 2,295
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
2019-09-12 Grant 450,000 $0.00
Outlook Therapeutics Inc OTLK
Stock Option (Right to Buy) · derivative
2019-02-19 Grant 800,000 $0.00
Outlook Therapeutics Inc OTLK
Common Stock
2019-02-07 Buy 25,000 $0.90 22,500
Outlook Therapeutics Inc ONS
Common Stock
2018-09-18 Sell 10,100 $0.87 8,787
Outlook Therapeutics Inc ONS
Stock Option (Right to Buy) · derivative
2018-08-01 Grant 500,000 $0.00
Outlook Therapeutics Inc ONS
Common Stock
2017-12-22 Sell 26,165 $1.13 29,566
Outlook Therapeutics Inc ONS
Common Stock
2016-12-21 Grant 50,000 $0.00
Arno Therapeutics Inc ARNI
Stock Option (right to buy) · derivative
2014-02-24 Grant 223,445 $0.00
Tamir Biotechnology Inc ACEL
Common Stock (Right to Buy) · derivative
2012-07-23 Grant 400,000 $0.00
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com